Watch for continued execution on the Medical-Surgical spin-off and synergy from the Apollo partnership. The raised guidance signals confidence in sustained 12-14% EPS growth, which could drive further multiple expansion. Monitor the Q1 FY2027 call for progress on segment separation.
Price Chart
Executive Summary
McKesson reported a strong Q4 FY2026 with GAAP EPS of $13.71 (+37% YoY) and Adjusted EPS of $11.69 (+16% YoY) on revenue of $96.3B (+6% YoY). Full year Adjusted EPS grew 18% to $39.11, above long-term targets. The company raised FY2027 Adjusted EPS guidance to $43.80-$44.60 (12-14% growth), announced a $5B share repurchase increase, and signed a deal for Apollo Global to acquire a 13% minority stake in its Medical-Surgical segment.
Key Financial Metrics
Key Facts
- Q4 FY2026 GAAP EPS $13.71 (up 37% YoY), Adjusted EPS $11.69 (up 16% YoY)
- Q4 revenue $96.3B (up 6% YoY), full year revenue $403.4B (up 12% YoY)
- FY2027 Adjusted EPS guidance $43.80-$44.60 (12-14% growth)
- $5.0B increase to share repurchase authorization, total $7.7B; $2.25B ASR completed in Q4
- Apollo Global to acquire ~13% minority stake in Medical-Surgical segment
- Cash flow from operations $3.4B and Free Cash Flow $3.2B in Q4
Financial Impact
Strong earnings beat with 16% adjusted EPS growth, raised guidance, and significant capital return
Risk Factors
- Opioid litigation remains a long-term overhang with $5.1B in long-term litigation liabilities
- Execution risk on Medical-Surgical separation and minority stake closing
- Potential headwinds from branded pharmaceutical pricing pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000927653-26-000066 |
| Document: mck-20260507.htm | 0000927653-26-000066 |
| Document: 0000927653-26-000066-index-headers.html | 0000927653-26-000066 |
| Document: 0000927653-26-000066-index.html | 0000927653-26-000066 |
| Document: 0000927653-26-000066.txt | 0000927653-26-000066 |
| 8-K Data (Synthetic) | 0000927653-26-000066 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 4w ago | 8-K | $885.32 $851.02 | ▼ −3.87% | ▼ −3.93% | $898.82 (+1.52%) |
Jul 1, 2026 13w ago | 8-K | $768.06 $888.56 | ▲ +15.69% | ▲ +17.87% | $898.82 (+17.02%) |
Jun 30, 2026 13w ago | DEFA14A | $768.06 $888.56 | ▲ +15.69% | ▲ +17.87% | $898.82 (+17.02%) |
Jun 12, 2026 15w ago | DEFA14A | $779.78 $812.28 | ▲ +4.17% | ▲ +4.92% | $898.82 (+15.27%) |
Jun 12, 2026 16w ago | 8-K | $784.05 $805.96 | ▲ +2.79% | ▲ +1.01% | $898.82 (+14.64%) |
Jun 8, 2026 16w ago | Insider Cluster | $766.64 $784.23 | ▲ +2.29% | ▲ +0.66% | $898.82 (+17.24%) |
Jun 3, 2026 17w ago | Insider Cluster | $739.40 $768.06 | ▲ +3.88% | ▲ +5.00% | $898.82 (+21.56%) |
Jun 2, 2026 17w ago | Insider Cluster | $736.15 $768.06 | ▲ +4.34% | ▲ +6.15% | $898.82 (+22.10%) |
May 27, 2026 18w ago | Insider Cluster | $756.13 $766.55 | ▲ +1.38% | ▲ +3.67% | $898.82 (+18.87%) |
May 27, 2026 18w ago | Insider Cluster | $756.13 $766.55 | ▲ +1.38% | ▲ +3.67% | $898.82 (+18.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access